Primary cytomegalovirus infectious colitis complicating Crohn's disease successfully treated with oral valganciclovir

Venkataraman Subramanian1, Caroline Finlayson, Thomas Harrison

  • 1Department of Gastroenterology, St George's Healthcare NHS Trust, Blackshaw Road, London SW17 0QT, United Kingdom. venkat@nottingham.ac.uk

Insights

Primary cytomegalovirus (CMV) colitis is rare in adults with inflammatory bowel disease (IBD). This case highlights a young woman with Crohn's colitis who experienced a primary CMV infection, successfully treated with antiviral therapy.

Area of Science:

  • Gastroenterology
  • Virology
  • Immunology

Background:

  • Cytomegalovirus (CMV) colitis in inflammatory bowel disease (IBD) patients typically results from viral reactivation.
  • Primary CMV infections are uncommon in adult IBD patients, and immunosuppressive therapy increases infection risk.

Observation:

  • A 26-year-old female with underlying Crohn's colitis presented with symptoms suggestive of a primary CMV infection.
  • Diagnostic findings included a positive CMV IgM titer, low-avidity IgG antibodies, high plasma CMV DNA levels, and immunohistological confirmation of CMV in the colon.

Findings:

  • The patient received intravenous ganciclovir, leading to a decrease in plasma CMV DNA.
  • Oral valganciclovir was administered for completion, resulting in undetectable plasma CMV DNA levels.

Implications:

  • This case underscores the possibility of primary CMV colitis in adult IBD patients, even without a history of reactivation.
  • Early diagnosis and prompt antiviral treatment are crucial for managing primary CMV colitis in IBD.
  • Further research may elucidate risk factors and optimal management strategies for primary CMV infections in this population.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...